Ronald J. Pabis

Ronald J. Pabis is a seasoned patent litigation attorney and a Partner at Tensegrity Law Group LLP, where he represents technology companies and innovators in patent litigation, licensing, and other intellectual property disputes. His practice encompasses a broad range of technologies, including networking, semiconductor, semiconductor packaging, software, mechanical systems, and medical devices. Tensegrity Law Group also highlights its experience in life sciences technologies, including biotechnology and medical devices.

While his sole tracked appearance in the provided data is on the plaintiff side for 10x Genomics, Inc. et al. v. Vizgen, Inc., Mr. Pabis's professional profile indicates extensive experience representing both patent owners and accused infringers across various industries.

Mr. Pabis played a significant role in the prominent 10x Genomics v. Vizgen litigation, contributing to a global settlement favorable to 10x Genomics, which included the dismissal of Vizgen's patent and state-law counterclaims. His team also secured a summary judgment dismissal of Vizgen's antitrust counterclaims, which had sought over $1 billion in damages. In a related matter, 10x Genomics v. NanoString (later acquired by Bruker), Mr. Pabis was part of the counsel that achieved a $31 million jury award for 10x Genomics and Prognosys, finding willful infringement, and subsequently secured a permanent injunction and a global settlement. He also has experience with Section 337 investigations before the U.S. International Trade Commission.

An experienced trial lawyer, Mr. Pabis has appeared before the Patent Trial and Appeal Board (PTAB) in inter partes review (IPR) proceedings. He was admitted to the Florida bar in 1994 and the District of Columbia bar in 2001. He earned his J.D., cum laude, from Albany Law School of Union University in 1994 and a B.S. from Hobart and William Smith Colleges in 1988.